BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hasan N, Imran M, Kesharwani P, Khanna K, Karwasra R, Sharma N, Rawat S, Sharma D, Ahmad FJ, Jain GK, Bhatnagar A, Talegaonkar S. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int J Pharm 2021;599:120428. [PMID: 33662465 DOI: 10.1016/j.ijpharm.2021.120428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ozgenc E, Karpuz M, Arzuk E, Gonzalez-alvarez M, Sanz MB, Gundogdu E, Gonzalez-alvarez I. Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies. ACS Omega. [DOI: 10.1021/acsomega.2c03023] [Reference Citation Analysis]
2 Mohammed Y, Holmes A, Kwok PCL, Kumeria T, Namjoshi S, Imran M, Matteucci L, Ali M, Tai W, Benson HAE, Roberts MS. Advances and future perspectives in epithelial drug delivery. Adv Drug Deliv Rev 2022;186:114293. [PMID: 35483435 DOI: 10.1016/j.addr.2022.114293] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nikhat A, Hasan N, Iqbal Z, Kesharwani P, Talegaonkar S. Enhanced transdermal delivery of lutein via nanoethosomal gel: Formulation optimization, in-vitro evaluation, and in-vivo assessment. Journal of Drug Delivery Science and Technology 2022;73:103447. [DOI: 10.1016/j.jddst.2022.103447] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Moayeri A, Mehdizadeh R, Karimi E, Aidy A, Ghaneialvar H, Abbasi N. Thymol Nanopolymer Synthesis and Its Effects on Morphine Withdrawal Syndrome in Comparison With Clonidine in Rats. Front Behav Neurosci 2022;16:843951. [DOI: 10.3389/fnbeh.2022.843951] [Reference Citation Analysis]
5 Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs. CNS Drugs 2022. [PMID: 35759210 DOI: 10.1007/s40263-022-00930-4] [Reference Citation Analysis]
6 Dubey SK, Dey A, Singhvi G, Pandey MM, Singh V, Kesharwani P. Emerging trends of nanotechnology in advanced cosmetics. Colloids Surf B Biointerfaces 2022;214:112440. [PMID: 35344873 DOI: 10.1016/j.colsurfb.2022.112440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rawal SU, Patel BM, Patel MM. New Drug Delivery Systems Developed for Brain Targeting. Drugs 2022. [PMID: 35596879 DOI: 10.1007/s40265-022-01717-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nguyen T, Duong V. Solid Lipid Nanoparticles. Encyclopedia 2022;2:952-73. [DOI: 10.3390/encyclopedia2020063] [Reference Citation Analysis]
9 Imran M, Paudel KR, Jha SK, Hansbro PM, Dua K, Mohammed Y. Dressing of multifunctional nanoparticles with natural cell-derived membranes for the superior chemotherapy. Nanomedicine (Lond) 2022. [PMID: 35451313 DOI: 10.2217/nnm-2022-0051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ahmed MZ, Gupta A, Warsi MH, Ali AMA, Hasan N, Ahmad FJ, Zafar A, Jain GK. Nano Matrix Soft Confectionary for Oral Supplementation of Vitamin D: Stability and Sensory Analysis. Gels 2022;8:250. [PMID: 35621548 DOI: 10.3390/gels8050250] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Danish SM, Gupta A, Khan UA, Hasan N, Ahmad FJ, Warsi MH, Ali AMA, Zafar A, Jain GK. Intranasal Cerium Oxide Nanoparticles Ameliorate Cognitive Function in Rats with Alzheimer’s via Anti-Oxidative Pathway. Pharmaceutics 2022;14:756. [DOI: 10.3390/pharmaceutics14040756] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hasan N, Imran M, Sheikh A, Saad S, Chaudhary G, Jain GK, Kesharwani P, Ahmad FJ. Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. J Drug Target 2022;:1-17. [PMID: 35321629 DOI: 10.1080/1061186X.2022.2056188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kasina V, Mownn RJ, Bahal R, Sartor GC. Nanoparticle delivery systems for substance use disorder. Neuropsychopharmacol . [DOI: 10.1038/s41386-022-01311-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Motawea A, Abd El Hady WE, Ahmed El-Emam G. The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis. Drug Deliv 2022;29:906-24. [PMID: 35297699 DOI: 10.1080/10717544.2022.2050847] [Reference Citation Analysis]
15 Imran M, Jha SK, Hasan N, Insaf A, Shrestha J, Shrestha J, Devkota HP, Khan S, Panth N, Warkiani ME, Dua K, Hansbro PM, Paudel KR, Mohammed Y. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems. Pharmaceutics 2022;14:586. [DOI: 10.3390/pharmaceutics14030586] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dale O. Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opin Drug Metab Toxicol 2022;18:203-17. [PMID: 35500297 DOI: 10.1080/17425255.2022.2072728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kataria I, Shende P. Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management. Chem Phys Lipids 2022;:105177. [PMID: 35122739 DOI: 10.1016/j.chemphyslip.2022.105177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Elkarray SM, Farid RM, Abd-alhaseeb MM, Omran GA, Habib DA. Intranasal repaglinide-solid lipid nanoparticles integrated in situ gel outperform conventional oral route in hypoglycemic activity. Journal of Drug Delivery Science and Technology 2022;68:103086. [DOI: 10.1016/j.jddst.2021.103086] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Reference Citation Analysis]
20 Modi D, Nirmal J, Warsi MH, Bhatia M, Hasan N, Kesharwani P, Jain GK. Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease. Colloids Surf B Biointerfaces 2021;211:112255. [PMID: 34942465 DOI: 10.1016/j.colsurfb.2021.112255] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
21 Singh A, Maharana SK, Shukla R, Kesharwani P. Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 2021;110:181-94. [DOI: 10.1016/j.procbio.2021.08.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Singh V, Kesharwani P. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. J Biomater Sci Polym Ed 2021;:1-28. [PMID: 34078252 DOI: 10.1080/09205063.2021.1938859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]